Page 1

Ceryvyn Therapeutics Limited Appendix 4E Preliminary final report 1. Company details Name of entity : ABN : Reporting period : Previous period : Ceryvyn Therapeutics Limited ( formerly known as Opthea Limited ) 32 006 340 567 For the year ended 30 June 2026 For the year ended 30 June 2025 Note : The financial figures provided are in Australian dollars . 2. Results for announcement to the market Profit from ordinary activities after tax attributable to the owners of Ceryvyn Therapeutics Limited up 231.6 % to Profit for the year attributable to the owners of Ceryvyn Therapeutics Limited up 231.6 % to Comments A $ ' 000 330,445 330,445 The profit for the consolidated entity after providing for income tax amounted to A $ 330 million ( 30 June 2025 : loss of A $ 251 million ) . Current year profit is driven by gain on derecognition of Development Funding Agreement ( DFA ) of $ A357 million . 3. Net tangible assets Net tangible assets per ordinary security 4. Control gained over entities Not applicable . 5. Loss of control over entities Not applicable . 6. Shareholder distributions Current period There were no dividends paid , recommended or declared during the current financial period . Previous period There were no dividends paid , recommended or declared during the previous financial period . 7. Dividend reinvestment plans Not applicable . Reporting period Previous period Cents Cents 2.16 ( 24.93 )